Page 327 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 327

TC-12


               Suppression       of     triple-negative      breast     cancer     growth       by    the

               immunomodulatory glycolipids


                                                       1
                                 #,1
                                                                                                       1,2
               Yi-Hsiang Wang,  Meng-Ting Chang,  Yi-Fan Chen,  Qu-Xuan Wu,  Yi-Ting Wang,
                                                                      1,2
                                                                                       1
               Juimin Chang  Lie-Fen Shyur,*    ,1,2  Tai-Na Wu*
                                                               ,1,2
                              1

               1  Agricultural Biotechnology Research Center, Academia Sinica, Taipei 115, Taiwan
               2  Institute of Biotechnology, National Taiwan University, Taipei 106, Taiwan
               * E-mail: taina@gate.sinica.edu.tw

               Abstract
                  Natural  killer T  (NKT)  cells  recognize  glycolipids  presented  by  the  CD1d  molecule  on
               dendritic cells (DCs). Upon stimulation, NKT cells produce large amounts of cytokines that
               activate other immune cells, thereby triggering anticancer responses. Plant-derived glycolipids
               with the potential to activate NKT cells may provide an alternative choice for the treatment of
               triple-negative breast cancer (TNBC) patients, because targeted therapies such as trastuzumab
               and hormonal drugs cannot be used. The immunomodulatory activities of the glycolipid (G)
               and its enriched fraction (A) were investigated in bone marrow-derived DCs (BMDCs) and the
               DC-T  coculture  system  in  vitro.  Flow  cytometry  and  enzyme-linked  immunosorbent  assay
               (ELISA) were used to evaluate the activation status of immune cells in vivo. G/A could activate
               DCs to upregulate CD40 and CD86 and to produce IL-12. G/A also stimulated conventional T
               and NKT cells to secrete interferon (IFN)-γ, but not IL-4, in vitro. The ratio of TNF-α to IL-4
               was significantly increased in the serum of A-treated mice. In the tumor microenvironment
               (TME), A induced DC to secrete IL-12 and stimulated T and NKT cell activation. However,
               only NKT cells showed a lower degree of exhaustion in the spleen and TME of tumor-bearing
               mice, leading to suppression of tumor growth in WT mice but not in NKT knockout mice. These
               results suggested that NKT cells were the major effector cells mediating A-induced anticancer
               effects. In conclusion, plant-derived glycolipids activated DCs and NKT cells and stimulated
               Th1-directed cytokine production, which together contribute to A-induced anticancer activities.

               Keywords: Glycolipid; NKT; DC; TNBC
   322   323   324   325   326   327   328   329   330   331   332